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Abstract
The tumor microenvironment has a significant impact on tumor development. Two important determinants in this
environment are hypoxia and lactic acidosis. Although lactic acidosis has long been recognized as an important factor in
cancer, relatively little is known about how cells respond to lactic acidosis and how that response relates to cancer
phenotypes. We develop genome-scale gene expression studies to dissect transcriptional responses of primary human
mammary epithelial cells to lactic acidosis and hypoxia in vitro and to explore how they are linked to clinical tumor
phenotypes in vivo. The resulting experimental signatures of responses to lactic acidosis and hypoxia are evaluated in a
heterogeneous set of breast cancer datasets. A strong lactic acidosis response signature identifies a subgroup of low-risk
breast cancer patients having distinct metabolic profiles suggestive of a preference for aerobic respiration. The association
of lactic acidosis response with good survival outcomes may relate to the role of lactic acidosis in directing energy
generation toward aerobic respiration and utilization of other energy sources via inhibition of glycolysis. This ‘‘inhibition of
glycolysis’’ phenotype in tumors is likely caused by the repression of glycolysis gene expression and Akt inhibition. Our
study presents a genomic evaluation of the prognostic information of a lactic acidosis response independent of the hypoxic
response. Our results identify causal roles of lactic acidosis in metabolic reprogramming, and the direct functional
consequence of lactic acidosis pathway activity on cellular responses and tumor development. The study also demonstrates
the utility of genomic analysis that maps expression-based findings from in vitro experiments to human samples to assess
links to in vivo clinical phenotypes.
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Introduction
The tumor microenvironment is characterized by oxygen
depletion (hypoxia), high lactate and extracellular acidosis (lactic
acidosis) as well as glucose and energy deprivation [1]. These
changes are largely caused by a combination of poor tissue
perfusion, abnormal tumor vasculature, uncontrolled proliferation
and dysregulated energy metabolism. These microenvironmental
features vary widely in different tumors, reflecting heterogeneity in
the metabolic status of individual tumors. They can also trigger
phenotypic changes in cancer cells and directly modulate biological
properties and clinical phenotypes. Although our understanding of
hypoxia has advanced tremendously in recent years, relatively little
is known about the role of other microenvironmental stresses,
especially lactic acidosis and glucose starvation.
The accumulation of lactic acid in solid tumors is often thought
to be caused by tumor hypoxia – a by-product of glycolysis as the
tumor cells shift to an anaerobic mode of energy production under
hypoxia or due to the altered metabolic profiles of cancer cells. In
spite of this apparent mechanistic link, these two factors exhibit
significant disparities in their spatial and temporal distribution in
tumors [2,3]. This may be due to the fact that some tumors exhibit
a predisposition toward glycolysis even in the presence of oxygen,
a phenomenon that is referred to as aerobic glycolysis or the
Warburg effect [4]. Some tumors may also possess greater capacity
to pump protons out to the extracellular space to create a reversed
pH gradient – acidic extracellular pH (pHe) and alkaline
intracellular pH (pHi) through higher expression of proton
transporters [5]. Additionally, lactic acid can accumulate in poorly
perfused tissue due to inefficient removal. Thus, it is important to
consider these two factors separately in understanding their
distinct contributions to tumor phenotypes.
Research on tumor microenvironments relies on our ability to
manipulate in vitro conditions of mammalian cell growth to re-
create the relevant stresses experienced in vivo. This offers a means
to explore the roles of individual environmental factors on cellular
behavior and phenotype. Genetic and pharmacological manipu-
lation can then be applied to explore the molecular mechanisms
and genetic circuitry underlying cellular responses. Such studies
typically observe in vitro cellular behavior and make inferences
about contributions to tumor progression in vivo. For example,
hypoxia, when applied in vitro, has been shown to promote
angiogenesis, cellular migration and energy consumption, thus
providing the potential mechanisms for its association with poor
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cultured cells, has been shown to trigger calcium signaling [8],
gene expression of angiogensis (e.g. VEGF, IL8) [9,10,11], HIF1a
stabilization [12], cell death [13] and affect gene expression
[14,15,16]. Recent studies also use genomic analysis to identify the
cellular response to acidosis and high lactate [14,16]. These results
are summarized in several nice reviews [17,18,19]. However,
inference using these observations from in vitro perturbations to in
vivo cancer phenotypes is frequently challenging and indirect. Gene
expression microarray signatures have provided a solution to this
gap since they afford an opportunity to develop a surrogate
phenotype of the in vitro state which can then be assessed in the in
vivo state. This approach generates gene expression signatures from
perturbations in cultured cells in vitro to represent a defined
biological process [20,21,22], which in turn can serve as a
common phenotype to recognize similar molecular features in
human cancer samples in vivo. Using this approach, we have
previously shown that the wound healing, hypoxia responses and
various oncogenic mutations can play important roles in tumor
progression [20,21,23]. Our current study applies this strategy to
lactic acidosis, aiming to elucidate the casual roles of lactic acidosis
at a molecular level and evaluate the prognostic implications. The
analysis reported in this manuscript investigates these molecular
mechanisms through integrative genomic analysis of lactic acidosis
responses from both in vitro culture cells and in vivo human cancers.
Results
Dissection of Gene Expression Responses of Hypoxia and
Lactic Acidosis
To characterize the gene expression program generated in
response to lactic acidosis, hypoxia, and combined lactic acidosis
and hypoxia, we made use of human mammary epithelial cells
(HMEC) brought to replicative arrest by growth factor/serum
withdrawal for 24 hours. Since the HMEC represent normal
epithelial cells with intact signaling components, the response
elicited in HMECs is likely to reflect the cellular response not
biased by genetic mutations present in cancer cell lines. We
exposed HMECs to four different culture environments for
24 hours in triplicate samples: 1) control – ambient oxygen level
(,21%O2) with neutral pH; 2) lactic acidosis – 25 mM lactic
acidosis with pH 6.7; 3) hypoxia (2% O2) with neutral pH; 4)
combined lactic acidosis and hypoxia. We did not find a significant
change in media pH at the end of the 24 hour culture. The gene
expression of these HMEC samples were interrogated with
Affymetrix GeneChip U133 plus 2.0 arrays to measure the
expression of more than 54,000 probe sets and at least 47,000
transcripts and variants. Gene expression profiles of cellular
responses to hypoxia, lactic acidosis and combined stresses were
first normalized by RMA, mean centered and filtered with the
criteria of at least 2 (out of 3 samples in each experimental
condition) observations with at least 1.75 fold changes to select
4722 probes sets. A clustering analysis on these genes revealed that
hypoxia and lactic acidosis induced distinct sets of genes
(Figure 1A). The hypoxia induced gene clusters included CA9,
stanniocalcin1, EGLN3, BNIP3 and many of the genes seen in our
prior studies with spotted cDNA arrays [21] (Figure 1B).
Interestingly, induction of some hypoxia-induced genes (e.g.
CA9, Stanniocalcin1) was abolished by simultaneous lactic acidosis
(Figure 1B), consistent with previous studies [24,25].
Compared with hypoxia, the lactic acidosis response is more
dramatic with alterations of many more genes. Genes induced by
lactic acidosis included: PLAUR, ERBB3, CD55, interleukin 15,
CXCL16, angiogenin and MHC class I genes (Figure 1B). For a
subset of these lactic acidosis-induced genes, the degree of
induction was further enhanced by the combined stresses of lactic
acidosis and hypoxia. Among genes repressed by lactic acidosis,
many are involved in cell cycle, cell proliferation and glucose
metabolism (Figure 1B). We further confirmed the induction of
ERBB3, CD55, and PLAUR in response to lactic acidosis, and to
the combination of hypoxia with lactic acidosis, via real-time PCR
(Figure 1C).
A supervised analysis of the full set of data on all 47,000 probe
sets was performed using Bayesian multivariate regression analysis
(BFRM) that has been utilized in a number of prior studies [26,27]
(Text S1). This analysis includes the ability to use housekeeping
gene information on each chip in order to automatically correct
for gene-sample specific assay artifacts. The multivariate analysis
computes, among other things, gene-specific probabilities of
expression changes resulting from lactic acidosis or hypoxia stress
(Table S1). At a threshold of probability of expression change of
0.99 (Bayesian significance of 1%) we find 217 genes whose
expression is significantly altered by hypoxia and 1585 genes by
lactic acidosis; only 54 genes are affected by both individual
treatments (Figure 1D). Cellular responses to lactic acidosis are
more dramatic and wide-spread than the responses to hypoxia,
and involve substantially distinct gene sets (Figure 1B, D).
To survey the molecular pathways triggered by lactic acidosis
and hypoxia, we analyzed the Gene Ontology (GO) enrichment in
the genes induced and repressed by hypoxia and lactic acidosis
using GATHER [28]. Among the genes induced by lactic acidosis,
we found enrichment for G-protein coupled receptor signaling,
antigen processing and presentation, and cellular catabolism
(Table S2). The top GO terms repressed by lactic acidosis were
genes involved in cell cycle, RNA metabolism and RNA
processing (Table S2). On the other hand, the top GO terms
enriched in the hypoxia-induced genes included hexose metabo-
lism, glycolysis, glucose metabolism and glucose catabolism (Table
S3); while the GO terms enriched in the hypoxia-repressed genes
included cell cycles and RNA metabolism (Table S3). Further-
more, we compared the GO terms enriched when cells are
exposed to hypoxia and lactic acidosis together (Table S4).
Previous studies have shown that lowering the extracellular pH
from 7.4 to ,6.7 will lead to a slight lowering of intracellular pH
(pHi) from 7.4 to 6.9–7.0, which is likely to be mediated by
monocarboxylate transporter (MCT) proteins [29,30]. Given the
Author Summary
It is well recognized that tumor microenvironments play
an important role in modulating tumor progression in
human cancers. Although previous studies have highlight-
ed the importance of hypoxia, there is limited knowledge
on the effects of other components in tumor microenvi-
ronments. Therefore, we use gene expression to compare
and analyze how cells respond to lactate, acidity, and
hypoxia, as well as how these responses can be utilized to
predict the clinical outcomes of patients with breast
cancers. We uncover an unexpected association with
better clinical outcome of the strong lactic acidosis and
acidosis response in breast cancers as a result of their
abilities to inhibit glycolysis and favor oxidative phosphor-
ylation for energy generation. This effect is caused by not
only the repression of the gene expression of glycolysis
genes but also the inhibition of Akt activation of cells
exposed to lactic acidosis and acidosis. In conclusion, we
propose that lactic acidosis and acidosis to be considered
as independent prognostic factors for human cancers.
Lactic Acidosis Response in Cancer
PLoS Genetics | www.plosgenetics.org 2 December 2008 | Volume 4 | Issue 12 | e1000293Figure 1. Overview of the cellular responses to hypoxia and lactic acidosis. (A,B) The gene expression response of HEMC is shown when
exposed to control, hypoxia, lactic acidosis and combined hypoxia and lactic acidosis conditions. 4722 genes with expression variations of at least
1.75 fold in two samples were selected and hierarchically clustered. Genes induced by hypoxia (vertical blue bar), lactic acidosis (pink), and repressed
by lactic acidosis (orange) are marked and further expanded in (B). (C) The expression of three lactic acidosis-induced genes ERBB3, CD55 and PLAUR
normalized by actin-beta were confirmed by real time RT-PCR. Similar results were observed when normalized by another control gene, B2M (D) Venn
diagram showing the number of genes changed by lactic acidosis (1585 genes), hypoxia (217 genes) and overlap (54 genes) for whom the probability
of an expression change exceeded 0.99. (E, F) The expression of genes comprising hypoxia (E) and genes comprising lactic acidosis (F) gene
signatures was shown in respective heat maps in all four indicated conditions.
doi:10.1371/journal.pgen.1000293.g001
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response to lactic acidosis, we analyzed this family of proteins
under both hypoxia and lactic acidosis (Table S5). We found that
MCT-4 was induced significantly under hypoxia and repressed
under lactic acidosis. The induction of MCT-4 by hypoxia has
been previously reported [31].
To further assess the extent to which the hypoxia and lactic
acidosis response overlaps, we used binary logistic regression to
estimate the probability of activation for the overall hypoxia and
lactic acidosis pathways revealed in gene expression under
individual conditions. We first used the control vs. hypoxia (for
hypoxia probability) and control vs. lactic acidosis (for lactic
acidosis probability) groups to provide the training sets to generate
respectively hypoxia (Figure 1E) and lactic acidosis (Figure 1F)
gene signatures. These signatures were then used to estimate their
probability in the remaining two groups of samples in the same
experiment. We found that the there is only marginal hypoxia
pathway activation evident in lactic acidosis samples compared to
controls (0.158 (control) vs. 0.286 (lactic acidosis), p=0.14, Figure
S1A). A similar analysis on the lactic acidosis pathway in hypoxia
response samples indicated slightly elevated levels of lactic acidosis
relative controls (0.362 (hypoxia) vs. 0.231 (control), p=0.005,
Figure S1B). We also used the BFRM analysis to identify genes
which are altered only in the presence of both hypoxia and lactic
acidosis. At a threshold of 99% probability, we found 127 induced
genes and 320 repressed genes in the presence of both hypoxia and
lactic acidosis (Figure S2A, B). Among the GO terms enriched in
the induced genes were several transcription factors involved in
regulating transcriptional activities (ATF3, YY1, CPEB2/3,
SAP18, SREBF2, Figure S2A). Among the GO terms enriched
in the repressed genes were genes encoding proteins involved in
apoptosis process (FADD, CASP6, PDCD6, ERCC3, Figure S2B).
The down-regulation of these pro-apoptotic genes may be
important in maintaining the cellular survival during the
simultaneous presence of both environmental stresses.
Dissection of Gene Expression Responses of Lactosis and
Acidosis
High lactate (lactosis) and low pH (acidosis) often co-exist in
tumor lactic acidosis, but these two factors are not necessarily
present simultaneously. To determine the respective contributions
of lactosis and acidosis in the lactic acidosis response, we created
culture conditions to separate the lactic acidosis condition (pH 6.7
created by 25 mM lactic acid) into lactosis (25 mM sodium lactate
with neutral pH) and acidosis (pH 6.7 created by HCl) conditions.
We analyzed the transcriptional responses of HMECs under
lactosis and acidosis via microarrays. Gene expression profiles of
the cellular responses to lactosis and acidosis were normalized by
RMA, mean centered and filtered with the criteria of at least 4 (out
of 6 sample in each experimental condition) observations with at
least 1.75 fold change. 213 probes were identified and clustered in
Figure 2A. Acidosis induced a much more dramatic change in
gene expression than lactosis. Acidosis-induced genes include
many of the genes also induced by lactic acidosis in our previous
analysis (Figure 1B). We also confirmed with realtime RT-PCR of
the induction of ERBB3 and SOD2 in response to acidosis (Figure
S3). The acidosis gene signatures were determined by comparing
the 6 control vs. 6 acidosis samples (Figure 2B). Most genes in the
acidosis gene signature were not altered under lactosis (Figure 2B).
To assess the relative contributions of acidosis and lactosis to the
lactic acidosis response, we compared the expression level of genes
changed in the three groups. We find a high concordance between
lactic acidosis and acidosis responses, with similar sets of genes
induced and repressed under these two stresses (Figure 2C, Table
S6). In contrast, this concordance is not present in other
comparisons between lactosis vs. lactic acidosis (Figure 2C),
hypoxia vs. lactic acidosis or hypoxia vs. acidosis treatment
(Figure 2D). This suggests that lactic acidosis (created by lactic
acid) and acidosis (created by HCl) trigger similar genetic
responses, distinct from genetic responses to lactosis and hypoxia.
Genomic Analysis of Hypoxia and Lactic Acidosis
Response in Human Cancers
We previously showed that the hypoxia response elicited in
cultured epithelial cells provides a molecular gauge of hypoxia
response for cancerous human tissues in vivo and predicts poor
clinical outcome [21]. This involves projecting the in vitro gene
signature of hypoxia ‘‘response’’ or ‘‘pathway activity’’ into
numerical scores on each tumor sample in the in vivo expression
data to assess the corresponding predicted levels of hypoxia
pathway activity in each tumor. Similar approaches have been
used in other studies using in vitro generated signatures to infer in
vivo responses or pathway activities in tumors [20,21,23,32,33].
The hypoxia response signature was evaluated in a number of
breast data sets via a weighted average of the signature gene set
based principal components analysis (full details in Statistics
Supplement). Analysis of a Cox survival model indicates patients
with tumors showing higher levels of hypoxia pathway activity had
poorer clinical outcomes (Figure 3A, Miller), consistent with our
previous studies [21]. (Reported p-values are from the variable
relevant to the figure, pathway activity score for the indicated
pathway, used in a Cox survival model.) Completely concordant
results were also observed in three other breast cancer expression
studies with different stages of diseases (Figure 3A). These datasets
include a study of 286 lymph node negative early breast cancers
from NKI (Wang), and two studies of invasive breast carcinomas
(Sotiriou, Pawitan) [34,35]. Similar trends are present but not
statistically significant in one smaller study of 82 breast cancers
with information on distant metastasis [36] (data not shown).
Given the perceived relation of lactic acidosis with hypoxia in
tumors, we evaluated the prognostic value of the lactic acidosis
signature using the same statistical approach. We found that tumors
with high lactic acidosis response signatures have significantly
improved overall survival, in contrast to that for hypoxia response
signature. This association with favorable clinical outcomes is
consistent across all four breast cancer datasets with their different
target populations and stages of cancers (Figure 3B). Given the
similarity of lactic acidosis and acidosis signatures, we also assessed
the acidosis gene signature alone and confirmed that tumors with
high acidosis response signature activity exhibited better clinical
outcome and survival (Figure 3C). In the Miller dataset with
information on p53 status of individual tumors, we also found a
strong association between lactic acidosis and p53 status: the
estimated ‘‘lactic acidosis pathway activity’’ based on gene
expression is significantly higher in wild type p53 tumors than in
those with p53 mutations (p=3.288610
211) (Figure 3D).
Among the breast cancer patients included in the Sotiriou
dataset, 64 patients were treated with tamoxifen while the
remaining 125 patients were untreated. Both hypoxia and lactic
acidosis pathway signatures are predictive of poor and favorable
outcomes respectively in the patients treated with tamoxifen
(Figure S4A, B), but less so among the untreated patients in this
cohort (Figure S4C, D).
To understand whether the prognostic value of lactic acidosis is
evident in a cell autonomous manner, we tested the prognostic
value of the lactic acidosis signature in various breast cancer cell
lines grown in a controlled culture milieu. We used binary logistic
regression to determine the probability of acidosis response in each
Lactic Acidosis Response in Cancer
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distant metastasis [36]. The acidosis signature probability varied
greatly among different cell lines; cell lines with high acidosis
signature demonstrated low levels of aggression in the xenograft
model when compared to those with low acidosis signatures
(Figure 3E) [36]. This indicates that the prognostic information
contained in the acidosis signature reflects the intrinsic phenotypes
of these cancer cell lines.
We also tested the prognostic value of gene signatures reflecting
lactic acidosis response and hypoxia response in a multivariate
Figure 2. The cellular responses to lactosis and acidosis. (A) HMECs were exposed to three indicated environments: control, lactosis, and
acidosis. 213 genes with expression varied from the mean at least 1.75 fold in 4 samples were selected and hierarchically clustered. A cluster of genes
strongly induced by acidosis is shown (yellow vertical bar). (B) The expression of genes comprising acidosis gene signatures under indicated
conditions was shown in heat maps. The expression of genes selected by statistical analysis (see Text S1) for whom the probability of an expression
change under lactic acidosis (C) or hypoxia (D) exceeds 0.99 were shown under hypoxia/lactic acidosis or lactosis/acidosis. Most lactic acidosis-
induced/repressed genes are also induced/repressed by acidosis but not lactosis.
doi:10.1371/journal.pgen.1000293.g002
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signatures are included in the Cox survival model on all samples
for which we have survival, ER status, tumor size, and data on
node involvement, the p-values for lactic acidosis and hypoxia are
0.0379 and 0.0069 respectively. When we include these two
pathway variables along with clinical variables indicating ER
status, tumor size .2 cm and node involvement, the p-values are
.07, .008, .85, .0032 and .77 respectively. Dropping ER status and
node involvement (poor predictors for this dataset) gives p-values
of .06, .008, and .002.
We further evaluated parametric Weibull survival models
involving different combinations of clinical variables and expression
signatures. Figure S5 presents some summary survival curves
comparing ‘‘high’’ versus ‘‘low’’ risk groups based on samples
‘‘below’’ versus ‘‘above’’ the median predicted survival time. This
analysis shows that survival model involving lactic acidosis, hypoxia,
and node size perform almost identically to models involving all
variables (Figure S5A, B). Further, models involving just clinical
variables perform worse than those that include both clinical and
signatures. Thus the clinical and pathway variables provide
synergistic value in predicting outcomes in breast cancer patients.
Relationship between the Hypoxia and Lactic Acidosis
Responses in Human Breast Cancers
Since lactic acid production and accumulation in solid tumors is
likely to relate to the shift to glycolysis under hypoxia, a high
Figure 3. The prognostic significance of gene signatures reflecting hypoxia, lactic acidosis and acidosis response in human breast
cancers. The gene signatures in hypoxia (A), lactic acidosis (B), and acidosis (C) response were assessed in the four indicated breast cancer expression
datasets. The tumors stratified by the degrees of these responses were used to generate the Kaplan-Meier survival curves for the clinical outcomes
exhibiting high and low indicated responses are shown. (D) In the Miller dataset, the lactic acidosis response score is significantly higher among the
tumors with wild type p53 than mutant p53 (p=3.288610
211). (E) Acidosis response were also estimated for a group of breast cancer cell lines with
different metastatic abilities and found to be negatively correlated with tumor aggressiveness determined in xenografted mice [36].
doi:10.1371/journal.pgen.1000293.g003
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in solid tumors. What is the relationship between the degree of
hypoxia and lactic acidosis responses in the same tumors? With
our quantitative, probabilistic assessment of the pathway activities
based on tumor gene expression, we can directly investigate the
relationship between these two factors in individual tumors.
Unexpectedly, the lactic acidosis response score correlated
significantly in a negative fashion with the hypoxia score in all
four expression studies, with R ranging from 20.35 to 20.45 and
p values from 2.2E-7 to1.4E-15 (Figure 4A). Although this negative
correlation between the lactic acidosis and hypoxia responses is
somewhat unexpected, it is consistent with the findings that a
strong lactic acidosis response predicts favorable prognosis,
(Figure 3B) while strong hypoxia response predicts poor prognosis
(Figure 3A). To test the potential for synergistic value when both
gene signatures are combined in patient stratification, we found
the ability to predict survival is significantly improved when we
combine the two signatures in breast cancers survival prediction
(Figure 4B).
Lactic Acidosis Response Favors Aerobic Respiration as
Means of Energy Generation
To understand the unexpected association between lactic
acidosis response and favorable clinical outcomes, we compared
the pathway composition between tumors with high vs. low lactic
acidosis responses in all four expression datasets using Gene Set
Enrichment Analysis (GSEA) [37]. GSEA uses a Kolmogorov-
Smirnov statistic to determine whether specific biological processes
(represented by gene sets) are significantly enriched in a subset of
breast tumors with strong lactic acidosis response [37]. Among the
top gene sets enriched in tumors with strong lactic acidosis
responses, two biological processes are prominent: aerobic/
mitochondria respiration (e.g. Kreb cycles, electric transportation
and oxidative phophorylation) and the metabolism of fatty acids
Figure 4. The exploration of lactic acidosis response in breast cancers. (A) Scatter plots showing the relationship between the probability of
hypoxia response (Y-axis) and lactic acidosis response (X-axis). Each point in the scatter plots represents a single tumor from the indicated breast
cancer data sets. The overall correlation (R) and probability (p) between hypoxia and lactic acidosis signatures across all samples is shown for the
indicated data set. (B) The tumors in the indicated breast cancer data set are separated into four groups based on hypoxia and lactic acidosis
responses. Kaplan-Meier curves for the clinical outcomes of these four groups of tumors are shown with indicated colors. (C) The top ten genesets
based on normalized enrichment score (NES) from GSEA analysis for the difference in pathway composition between the tumors with high vs. low
lactic acidosis responses in the Pawitan data. (D) The breast samples in the Pawitan data was arranged from left to right by descending lactic acidosis
score (top row). The expression of genes in TCA cycles in these samples is shown in heat map (orange means higher expression whereas blue means
lower expression) together with lactic acidosis score.
doi:10.1371/journal.pgen.1000293.g004
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in the TCA cycles compiled by KEGG pathway database are
highly enriched in the breast cancers with strong lactic acidosis
pathways in the Pawitan study (Figure S6). Several gene sets
representing aerobic respiration from other sources also show
significant enrichment. When all the samples in the Pawitan study
were ranked based on their lactic acidosis score, the tumors with
high lactic acidosis response tend to have higher expression level of
genes in TCA cycles (Figure 4D). In contrast, tumors with high
hypoxia response tend to have lower expression level of genes in
the TCA cycle (Figure S7). Thus a high lactic acidosis response
identifies a group of breast cancers enriched in the use of aerobic
respiration. It is interesting to note that several gene sets
representing amino acid and fatty acid metabolism are also
enriched in these tumors (Table S7), reflecting the distinct
metabolic profiles and mode of energy generation in tumors with
high lactic acidosis responses.
There are two major pathways for ATP-generation in mamma-
lian cells – glycolysis or aerobic respiration. One of the fundamental
properties of cancer cells is their preferential utilization of glycolysis
over aerobic respiration to produce ATP. The glycolytic phenotype
of cancer cells is thought to offer selective advantages since the
disruption of glycolysis phenotype (e.g. silencing of LDH-A) results
in stimulation of mitochondrial respiration and significantly
compromises their tumorigenicity and the proliferation under
hypoxia [38]. Our GSEA result suggests the lactic acidosis gene
signature can identify a subgroup of tumors with a higher level of
aerobic respiration and more favorable clinical outcomes. This
association between high lactic acidosis activity and strong aerobic
respiration is also consistent with its links to wild type p53
(Figure 3D) since p53 has been shown to redirect the metabolic
pathways toward aerobic respiration [39,40].
To investigate the possibility that lactic acidosis directly
modulates the balance of energy production, we measured its
influence on ATP production in cultured cells when aerobic
respiration is inhibited by rotenone. In control conditions without
hypoxia or lactic acidosis, we found that approximately 35 %of
ATP production in Siha cells is sensitive to rotenone at 48 hours
(Figure 5A). Under hypoxia, only 16% of ATP production was
sensitive to rotenone at 48hours, reflecting the increased use of
glycolysis for energy generation when oxygen is limited (Figure 5A).
In contrast, this balance is dramatically changed under lactic
acidosis with 72 % ATP production sensitive to rotenone. This
effect is even more dramatic at 72 hours – while 35% of ATP
production was sensitive to rotenone inhibition under control
conditions, this increased to 82% under lactic acidosis and
decreased to 18% under hypoxia (Figure 5A). We also tested the
contribution of ATP from glycolysis with 2-DG. At 48hours, we
found that 71 %of ATP production is sensitive to 2-DG. This is
increased to 77% under hypoxia and reduced to 63% under lactic
acidosis (Figure 5B). These results indicate that lactic acidosis
redirects energy production toward the aerobic respiration in vitro,
which may explain why lactic acidosis response can identify
tumors with higher level of aerobic respiration.
These data reveal the distinct manner by which lactic acidosis
and hypoxia redirect energy utilization – hypoxia favors the
glycolytic pathways while lactic acidosis favors the aerobic
respiration. This suggests these two stresses may impact cellular
metabolism in distinct manner and have synergic effects on ATP
inhibition when cells are exposed to simultaneous hypoxia and
lactic acidosis. We measured ATP production under control, lactic
acidosis, hypoxia and combined hypoxia and lactic acidosis. We
found that lactic acidosis and hypoxia reduced the ATP
production to ,50% and 63% respectively in 48 and 96 hours
(Figure 5C). This result indicates that while lactic acidosis also
caused a reduction in energy production similar to hypoxia. When
the cells were exposed to both hypoxia and lactic acidosis, ATP
production was dramatically decreased to about 17.3% (on
average) of the control cells (Figure 5C).
Gene Expression Change Involving Energy Production in
Hypoxia and Lactic Acidosis
To further understand how lactic acidosis and hypoxia modulate
the balance between the aerobic respiration and glycolysis, we
mapped their respective effects on gene expression onto the
framework of metabolic pathways in energy metabolism
(Figure 5D, E). From this analysis, we found that most genes in
the glycolytic pathways, including PFK, ALDO, GADPH, PGK,
PGM, ENO and PK, were significantly induced by hypoxia as
expected from previous studies [21] (Figure 5D, E). Hypoxia
induced the expression of LDHs, the enzymes required for the
conversion of pyruvate to lactate. Hypoxia also induced the
expression of gene encoding pyruvate dehydrogenase kinase 1
(PDK1), which inactivates the PDH by phosphorylation and
prevents the conversion of pyruvate into acetyl-CoA, the essential
substrate for TCA cycles during the aerobic respiration [41]. The
PDK1 induction under hypoxia directs energy generation towards
glycolysis instead of aerobic respiration [41]. Similarly, the average
expression of these glycolysis genes was induced under hypoxia
(Figure 5F). When these glycolysis genes are analyzed for their Gene
Ontology enrichment, the top GO terms, as expected, are processes
involved in the glycolysis and glucose metabolism (Table S8).
In contrast, expression levels of these glycolytic genes were
consistently repressed by lactic acidosis (Figure 5D, E). For
example, the expression levels of phosphofructokinase, fructose-
1.6-bisphophatase and lactate dehydrogenase were all induced by
hypoxia and repressed by lactic acidosis (Figure 5E). Lactic
acidosis reduced the expression levels of all these genes from both
the baseline level under normoxia and induced levels under
hypoxia (Figure 5F). The changes in expression levels of these
glycolysis genes are also shown (Table S9). Overall, hypoxia-
induced change in gene expression favors the utilization of
glycolytic pathways for energy generation whereas lactic acidosis
represses the glycolysis process and favors the use of aerobic
respiration as a mode of energy production, consistent with our
experimental data of higher reliance on aerobic respiration
(Figure 5A).
Under hypoxia, there was also a noticeable reduction in the
expression of the genes in the TCA cycles and other mitochondria
genes essential for aerobic respiration, consistent with previous
studies [42,43]. Lactic acidosis, by contrast, has no significant
effect on their expression levels. The in vivo relevance of these
changes in energy production by hypoxia and lactic acidosis was
tested by examining survival predictions based on signatures of
these two small sets of genes representing glycolysis and the TCA
cycle. When the hypoxia-induced changes of glycolysis are
projected into the same breast cancer expression studies, we
found that high glycolysis pathway activities have prognostic
significance similar to the significance of the whole hypoxia gene
signatures (Figure 5G). On the other hand, the tumors with strong
hypoxia-induced TCA pathways have entirely opposite effects –
they have significantly better clinical outcomes (Figure S8A).
Further, tumors with the high correlation between the glycolysis
genes with lactic acidosis have better survival (Figure 5H), similar
to the overall lactic acidosis gene signatures. Among the glycolysis
genes, the lactic acidosis response correlated negatively with the
hypoxia response in all four expression studies (Figure 5I). The
Lactic Acidosis Response in Cancer
PLoS Genetics | www.plosgenetics.org 8 December 2008 | Volume 4 | Issue 12 | e1000293Figure 5. Lactic acidosis directs toward aerobic respiration by inhibiting the expression of glycolytic genes (A,B). The contribution of
aerobic respiration and glycolysis to ATP generation under control, lactic acidosis and hypoxia is measured by the degree of inhibition of ATP
generation after treatment of rotenone (A) and 2-DG (B) at the indicated time after treatment. (C) The amount of ATP generation at different time
points under the indicated conditions. (D) The genes in the glycolysis pathways were up-regulated by hypoxia and down-regulated by lactic acidosis.
(E) The expression of genes listed as ‘‘glycolysis pathway’’ was extracted and clustered. (F) The mean expression values of the 53 glycolysis genes for
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hand, have no predictive value for clinical outcomes (Figure S8B).
Integrative Genomic Analysis Revealed that Lactic
Acidosis Inhibits Akt Activities
To further explore the signal transduction pathways of lactic
acidosis through genomic analysis, we compared the lactic acidosis
gene signatures with the database of ‘‘connectivity map’’ [44]
composed of the gene expression patterns elicited by 453 different
perturbations caused by 164 distinct small molecules. We assessed
the similarity between lactic acidosis response and each reference
expression profile in the data set with a nonparametric, rank-based
pattern-matching strategy based on the Kolmogorov-Smirnov
statistic [44]. From this analysis, the top perturbations positively
correlated with the lactic acidosis gene signatures were different
treatments of Wortmannin and LY-294002, two known inhibitors
of phosphoinositide 3-kinases (PI3 kinase) (Figure 6A, detailed in
Table S10). PI3 kinase phosphorylates phosphoinositides
PtdIns(3,4)P2 (or ‘‘PIP2’’) to PtdIns(3,4,5)P3 (or ‘‘PIP3’’) molecule,
which in turn recruit Akt to the cell membrane and trigger Akt
phosphorylation and activation. Akt activation, in turn, initiates a
cascade of cellular events from glucose uptake, energy utilization,
cell growth and proliferation to survival and motility, that drive
oncogenesis and tumour progression [45]. This association
between acidosis and PI3K inhibition is consistent with the
observations seen previously in muscle cells [46].
Gene signatures representingdifferentpathways canbeevaluated
with lactic acidosis response signature in the gene expression data
sets of breast cancer to further elucidate the molecular mechanisms
of lactic acidosis [20,21]. We evaluated this using several gene
signatures reflecting oncogenic pathway deregulation induced by
genetic manipulations [20]. In the three expression studies of breast
cancers [35,36,47], we found a consistent inverse relationship
(p,0.0001) between the acidosis and Akt pathway signatures –
tumors with strong acidosis response tend to manifest low Akt
pathway activities while tumors with low acidosis response manifest
high Akt pathway activities (Figure 6B and Table S11). This inverse
relationship was further noted in an independent mouse model of
prostate neoplasia with overexpression of constitutively activated
Akt [48] – the acidosis response is high in the normal prostate and
low in the prostate of the Akt transgenic mouse which exhibit sign of
prostate cancers (Figure 6C).
This inverse correlation between the lactic acidosis and Akt
pathway activity in the tumor expression data lead us to
hypothesize that lactic acidosis can inhibit the Akt pathway in
the tumor cells. This possibility is also consistent with the
correlation between lactic acidosis response and PI3K inhibition
noted in the connectivity map analysis. Since this observed
pathway activity seen in the gene expression may be caused by the
corresponding change in the Akt enzymatic activity, we formally
tested the effect of lactic acidosis on activation of Akt enzymatic
activity in prostate cancer cell line DU145 during serum exposure.
Growth of DU145 cells in a serum-free condition resulted in the
inhibition of the Akt enzymatic activity, as seen by the absence of
phosphorylation of Ser473 (Figure 6D). Upon exposure to serum,
the Akt enzymatic activity became activated in 30 minutes, as
indicated by the phosphorylation of Ser473 [49] (Figure 6D).
However, this serum-induced Akt activation was abolished when
the cells were simultaneously exposed to lactic acidosis during
serum exposure (Figure 6D). Even after lactic acidosis exposure
removed once media was changed to neutral pH during serum
exposure, this Akt inhibition still persisted (Figure 6D). This
suggests that Akt enzymatic and inferred pathway activity can be
abolished by prior exposure to lactic acidosis.
Lactic Acidosis Inhibits the Glycolytic Phenotypes of
Cancer Cells
Given the important role of the PI3K/Akt pathway in the
tumor glycolytic phenotypes [50], we explored whether lactic
acidosis, with its ability to inhibit Akt pathways, can inhibit
glycolysis phenotypes of cancer cells. This possibility is further
supported by the repression of gene expression in the glycolytic
pathways and increased reliance on aerobic respiration in lactic
acidosis. We examined the glucose consumption and lactate
production in two cancer cell lines – WiDr (colon cancer cell) and
SiHa (cervical cancer cell). When grown in a control environment
(condition 1) with ambient air, colon cancer cell WiDr exhibit
features of aerobic glycolysis with modest glucose consumption
and lactate production (Figure 6E). While 25 mM sodium lactate
(condition 3) alone did not affect the glucose consumption
significantly, all the remaining conditions (including lactic acidosis
(condition 2), acidosis at pH 6.7, pH 6.5 and pH 6.0 (condition 4,
5, 6, created by HCl) significantly decreased glucose consumption.
The acidosis-induced decrease in glucose consumption is also
accompanied by a corresponding decrease in lactate production.
This shows that lactic acidosis and acidosis lead to a significant
reduction in glycolysis. Both glucose consumption and lactate
production were increased under hypoxic conditions (0.5% O2).
This hypoxia-induced increase was also dramatically reduced
when cells were placed under lactic acidosis and acidosis
conditions (conditions 2, 4, 5, 6) but not lactosis. Similar effects
in decreasing glucose consumption and lactate production were
also seen for SiHa (Figure 6F) and mouse MEF cells. This
inhibition of glycolytic phenotypes by lactic acidosis can also
explain the increased reliance on aerobic respiration as well as the
ability of lactic acidosis response in identifying breast cancers with
higher level of aerobic respiration.
Taken together, we propose a model (Figure 6G) in which lactic
acidosis favors the utilization of aerobic respiration as the mode of
energy production by inhibiting the glycolysis pathways. This is
likely due to both the repression of expression of glycolysis genes
and the inhibition of Akt enzymatic and pathway activities. This
switch to aerobic respiration in vitro may also explain the ability of
lactic acidosis gene signatures to identify breast cancers enriched in
molecular pathways of aerobic respiration/mitochondria in vivo
and more favorable clinical outcomes. Thus, the lactic acidosis
gene signatures allow us to identify tumors with distinct metabolic
profiles and clinical phenotypes. The reciprocal exchange of in vitro
and in vivo global gene expression information via the common
language of microarrays greatly enhanced our understanding of
how individual microenvironmental stresses lead to relevant
clinical phenotypes.
each HMEC under hypoxia, lactic acidosis and hypoxia/lactic acidosis are calculated and shown. (G)(H) The expression of genes in the glycolytic
pathways under hypoxia and lactic acidosis were used to predict the pathways activity and stratified the indicated breast cancer samples. This small
set of genes recapitulated the result using the whole lactic acidosis and hypoxia gene signatures. (I) Scatter plots showing the relationship between
the probability of hypoxia response (Y-axis) and lactic acidosis response (X-axis) for genes in the glycolysis pathways. Each point in the scatter plots
represents a single tumor from the indicated breast cancer data sets. The probability (p) between hypoxia and lactic acidosis signatures across all
samples in the indicated data set is shown.
doi:10.1371/journal.pgen.1000293.g005
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PLoS Genetics | www.plosgenetics.org 10 December 2008 | Volume 4 | Issue 12 | e1000293Figure 6. Lactic acidosis inhibits Akt and glycolytic phenotypes of cancer cells. (A) PI3K inhibitors are highly ranked with lactic acidosis
signature in the connectivity map analysis. The ‘‘barview’’ is constructed from 453 horizontal lines, each representing an individual treatment
instance, ordered by their corresponding connectivity scores calculated with lactic acidosis signature (+1, top; 21, bottom) with the instances
corresponding to wormannin and LY-294002 were shown as black bars. Colors applied to the remaining instances reflect the sign of their scores
(green, positive; gray, null; red, negative). (B), (C) The relationship between the predicted Akt and Acidosis pathway activities in the gene expression
pattern of a breast cancer expression studies (B) and prostate tissue is shown between wild (WT) and Akt transgenic mouse (AKT-Tg) treated with
placebo or mTOR inhibitor RAD001. (D) The effect of lactic acidosis on Akt activation in DU145 cells during serum exposure. Indicated amount of
serum are added to the DU145 which have been placed in 0.2% serum conditions for 24 hours without (2) or with (+) 25 mM lactic acid. The same
amount of cell lysates of DU145 cultured under indicated conditions were separated, transferred to blot and probed with indicated antibodies. (E), (F)
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Lactic acidosis and hypoxia are two well recognized features in
human cancers. Although tumor lactic acidosis is often thought to
co-exist with hypoxia, relatively little is known about its cellular
response, relationship with hypoxia or its role in tumor
progression. Our current study presents, to our best knowledge,
the first genomic analysis of lactic acidosis activities in human
breast cancers in vivo. These analyses reveal that tumors exhibiting
strong lactic acidosis and acidosis responses are associated with
favorable clinical outcomes – in direct contrast to the poor clinical
outcome associated with strong hypoxia response. Through
various genomic analyses, this association with favorable outcomes
is likely to be explained by the ability of lactic acidosis and acidosis
to direct energy utilization toward aerobic respiration through the
inhibition of glycolysis. Lactic acidosis mediates this effect both by
inhibiting gene expression of glycolytic pathways and repressing
Akt activation. In contrast to hypoxia, lactic acidosis represses the
tumor ‘‘glycolytic’’ phenotype with the reduction of both glucose
consumption and lactate production in tumor cells. Since tumor
glycolysis is a crucial component of the malignant phenotypes and
confers a significant proliferative advantage during somatic
evolution [4], this ‘‘anti-Warburg’’ effect by lactic acidosis is likely
to contribute to favorable clinical outcomes seen in tumors with
strong lactic acidosis programs. The inhibition of Akt/glycolysis
may also hamper the adaptive shift to anaerobic glycolysis under
hypoxia and renders the cell vulnerable to energy depletion and
cell death in hypoxic environments [13]. For example, lactic
acidosis represses the LDH-A induction by hypoxia and LDH-A
inhibition by RNAi has been previously shown to lead to poor
tumor survival and diminished tumorgenicity [38].
A number of studies have now described the power in utilizing
large scale gene expression data to develop signatures representing
important biological states – in this context, the signature becomes a
surrogate phenotype that can be used to explore the biological
relevance in the diverse space of in vitro and in vivo systems, including
human tumors [20,51]. In this study, we have taken this approach
further to bring signatures together to develop a mechanistic
understanding of a clinically important biological process – lactic
acidosis response. By investigating its relationship with various
known molecular processes in the space of gene expression, we
uncovered a positive association with a different mode of metabolic
status (aerobic respiration and fatty acid/amino acid metabolism)
and an inverse relationship with the PI3K/Akt pathways. These
findings reveal the previously undefined complexity of lactic acidosis
response program. These in vitro observations, in turn, help to
explain the favorable clinical outcomes associated with strong lactic
acidosisresponse invivo. Thisuse ofgene expression data as common
phenotypes to facilitate the reciprocal exchange of information
between experimental perturbations in vitro and clinical phenotypes
in vivo has greatly enhanced our understanding of the lactic acidosis
response. We expect this approach is generally applicable and will
broadly enhance our understanding in other biological processes.
This unexpected result demonstrates the importance of analyzing
individual microenvironmental factors separately to determine their
respective contributions to tumor phenotypes.
One of the principal metabolic properties of cancer cells is their
preferential use of glycolysis for energy generation even in the
presence of oxygen (aerobic glycolysis). Warburg has speculated
that this is caused by defective or functionally impaired
mitochondria. Recent studies suggest that mutations affecting
mitochondrial DNA or enzymes of the TCA cycle might
contribute to tumor formation, tumor progression and the
Warburg effect. Two enzymes in the TCA cycle enzymes, SDH
and FH, are found to be tumor suppressor genes [52]. Given the
importance of the choice of glycolysis vs. aerobic respiration for
energy production in determining the tumor phenotypes and
clinical outcomes of cancer patients, the regulatory circuits
affecting for this choice have become subjects of intense
investigation. For example, hypoxia triggers coordinated changes
toward glycolysis through both the induced expression of genes
encoding glucose transporters and glycolytic enzymes and
repression of mitochondrial function [42,43]. Hypoxia also
induces the expression of PDK1. This phosphorylates and
inactivates pyruvate dehdrogenase (PDH), which converts pyru-
vate to acetyl-CoA. In addition, Akt activation also favors
glycolysis since it increases glucose transport and makes cancer
cells dependent on glucose for their survival [50]. The cellular rate
of glycolysis is also regulated on many levels, such as the
availability of oxygen/substrate, NAD/NADH, AMP/ATP ratio,
enzyme modification and allosteric inhibition. Other regulators, in
contrast, can direct the cells toward aerobic respiration and
suppress cancer phenotypes. For example, the tumor suppressor
gene p53 can redirect toward aerobic respiration by both inducing
genes required for aerobic respiration [39] and repressing genes
inhibiting glycolysis [40]. Since the accumulation of lactic acidosis
comes from the excess of product from the glycolysis, the
inhibition of glycolysis by lactic acidosis can be thought of as a
negative feedback. Extracellular acidity is determined both by the
abundance of different acidic substances (e.g. lactic acid, CO2)
[53] and the buffering capacity of the extracellular fluid. This
negative feedback mechanism may allow cells to avoid acidity-
induced cell death by adjusting the rate of glycolysis based on
extracellular pH. Given the association of lactic acidosis pathway
activity with favorable clinical outcomes, understanding the
mechanism by which lactic acidosis inhibits Akt and glycolysis
may lead to novel therapeutic strategies to modify tumor behavior.
The lactic acidosis gene signature can also be used to identify
cancers preferentially using aerobic respiration and therefore likely
to respond better to chemotherapeutics targeting mitochondrial
functions [54].
In addition to generation of ATP, glycolysis is responsible for
the generation of acetyl-CoA, which feeds into the TCA cycle for
aerobic respiration. Thus, the reduction in glycolysis under lactic
acidosis may imply a reduction in the amount of acetyl-CoA
derived from the glycolytic process. To maintain cellular energy,
cells may increase the use of other energy sources, such as the b-
oxidation of fatty acids as source of acetyl-CoA. Since Akt pathway
activity is known to suppress b-oxidation and thus energy
generation from fatty acids [50,55], Akt inhibition by lactic
acidosis may increase b-oxidation of fatty acid and thereby
compensate for the increased demand of acetyl-CoA for energy
generation. In support of this change in metabolic state, breast
cancers with strong lactic acidosis responses are highly enriched in
gene sets of fatty acid degradation and amino acid metabolism
(GSEA analyses). There is increased expression of PPAR-alpha
The amount (mM) of lactate production (orange) and glucose consumption (blue) in 48 hour per million of WiDr (E) and SiHa (F) cells under hypoxia
(left) or normoxia (right) with the following media conditions (1) control, (2) 25 mM lactic acidosis (pH 6.7), (3) 25 mM sodium lactate, (4) pH 6.7, (5)
pH 6.5, (6) pH 6.0. (G) The model of the differentially modulated the balance of glycolysis and aerobic respiration as means of energy generation
under control, hypoxia and lactic acidosis.
doi:10.1371/journal.pgen.1000293.g006
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acidosis response. Together, these in vivo and in vitro observations
indicate that lactic acidosis induces extensive and coordinated
changes in the mode of metabolism and energy utilization, which
in turn may account for their effects on the clinical phenotypes of
breast cancer.
These data suggest that the lactic acidosis-induced gene
expression program may have a direct causal role in impacting
tumor biology to affect clinical outcomes. It will be important to
understand what specific lactic acidosis-driven biological processes
underlie the phenotypic differences between groups of tumors
separated by lactic acidosis pathway activity. The mechanisms
underlying the variation in lactic acidosis responses in breast are
still unknown. There are three reasonable possibilities; variations
in the lactic acidosis-response program could reflect: 1) actual
variations in lactate and/or acidity in the tumors 2) cell-type-
specific variations in the magnitude of, or threshold for, the
response to bona fide lactate and/or acidity in tumors or 3)
inappropriate activation of the lactic acidosis response resulting
from genetic and/or epigenetic alterations in cancers. Given these
possibilities, it is important to note that several previous studies
have suggested that high level of tumor lactate is associated with
poor clinical outcomes in several solid tumors [56,57,58]. This is in
contrast to our results based on the analysis of lactic acidosis gene
signatures, but is not necessarily contradictory as the two may be
decoupled in tumors. It is relevant to note that acidosis was able to
impose strong selection pressure and likely contributes to the
observed responses seen in a group of tumors [4,14,18]. This
difference highlights the distinction between the measured
physiological parameters (pO2, lactate and acidity) and observed
cellular responses (hypoxia and lactic acidosis response genes) in
human cancers. For example, the expression of carbonic
anhydrase IX (CA9) expression is induced by hypoxia. Therefore,
CA9 is frequently used as an ‘‘endogenous’’ marker for low tumor
pO2 – bona fide hypoxia [59]. But tumor pO2 and hypoxia
response are two distinct measurements which may not exhibit
tight correlation in all instances. Although many studies have
concluded a low tumor pO2 is associated with CA9 expression,
other studies point out the lack of direct correlation between CA9
expression and pO2 [60,61,62]. In other studies, high levels of
tumor lactate [56,63] and acidic pH [64] are usually associated
with tumor metastasis or poor treatment response in solid tumors.
The discrepancy between high lactate in tumors as a predictor of
poor prognosis and strong lactic acidosis response as a predictor of
good prognosis strongly suggests a likely disentanglement between
measured physiological parameters and observed cellular respons-
es. This discrepancy may be due to continuous fluctuations in the
physiological parameters, different turnovers in the mRNA/
protein, cell type-specific variations in the responses or it may
result from genetic and/or epigenetic alterations in cancers
unrelated to the physiological parameters. It is therefore important
to determine whether these variations in the lactic acidosis
response program are associated with actual variations in lactate
and acidity in the tumors or result from other causes without
significant connections to tumor lactate or acidity [65].
It is widely believed that the intimate relationship between tumor
progression, tumor microenvironment and the response of the
tumor to that environment, when combined with other genetic and
clinical factors, offers promise for improving our understanding of
the heterogeneity of the disease. Progress in this direction will
require a substantial advance in our – currently limited – ability to
dissect the roles played by multiple characteristics of the tumor
microenvironment. We aim to develop this approach to further
dissect other various microenvironmental factors in cancers, such as
glucose starvation, reoxygenation and ATP depletion [1]. The
availability of this information will allow researchers to gradually
establish an integrative metabolic profile of human cancers.
Additionally, diverse genetic and molecular characteristics from
clinical data will help further elucidate heterogeneous properties of
tumors and lead to targeting treatments with better prognosis [26].
Materials and Methods
Cell Culture and Conditions Reflecting Different
Environmental Stresses
Human mammalian epithelial cells (HMEC) were cultured in
MEGM (Cambrex) and growth factors were withdrawn for 24 hrs
before being placed under different environmental stresses.
DU145 cells were cultured in RPMI1640 with 10% FBS, 1%
sodium pyruvate, 1% L-glutamine, 1% Hepes and 1% antibiotics
(penicillin, 10000 UI/ml; streptomycin, 10000 UI/ml). WiDr and
SiHa cells were cultured in DMEM with 10%FBS. Lactic acidosis
conditions were created with the addition of 25 mM lactic acid
(Sigma) to pH 6.7. Hypoxia was created by lowering the oxygen
level to 2%. Similarly, the lactosis condition was created with the
addition of 25 mM sodium lactate, while acidosis conditions were
created by titrating media to pH of 6.7 with HCl.
RNA Isolation and Microarray Analysis
RNAs were extracted by miRVana kits (Ambion) and
hybridized to Affymetrix Hu133 plus 2 genechips with standard
protocol. All microarray data are available on GEO (GEO
accession number GSE9649). Hierarchical clustering with weight-
ed average linkage clustering was performed after indicated data
filtering based on spot quality and variations in signal intensity as
described [66]. The analyses of microarrays from the lactic
acidosis/hypoxia and acidosis/lactosis experiments were per-
formed using a sparse ANOVA modeling framework outlined
and implemented in the software package, Bayesian Factor
Regression Models (BFRM)[67] with detailed parameter files
and normalized RMA data available in the supplementary section.
In the context of a designed experiment (having controls and
experimental groups) BFRM provides a probability of differential
expression for each gene and each experimental group. A
signature corresponding to each experimental group was compiled
by listing those genes with high probability of differential
expression as well as high levels of fold change in expression.
Principal components were then used to compute weights for each
gene such that the weighted average of expression levels showed a
clear ability to distinguish the relevant group from others in the
experiment. Expression levels of tumor samples on each of the
signatures were calculated according to the weighted average
obtained from this principal components analysis and after
subtraction of mean expression and doping control correction
factors. In order to distinguish differential survival associated with
expression level of a particular signature, the patient population
was split into high and low expression level groups and Kaplan-
Meyer survival curves were computed for each group.
Real Time RT-PCR
RNAs were reverse-transcribed to cDNAs with SuperScript II
reverse transcription kit following the manufacturer’s protocol
(Invitrogen). cDNAs were then used as the substrate for gene
expression level measurements by qPCR with Power SYBRGreen
PCR Mix (Applied Biosystems) and primers specific for ErbB3(-
Forward:CAGGGGTGTAAAGGACCAGA, Reverse:CGCCA-
GTAGAGAAAAGTGCC), CD55(Forward:AGGTCCCAC-
CAACAGTTCAG, Reverse:AAAATGCTTGGTTGTCCTGG),
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CACAGCATTTTGGTGGTGA), SOD2(Forward:TTTGGG-
GACTTGTAGGGATG, Reverse:AGAAAGCCGAGTGTT-
TCCCT), Actin-beta(Forward:CTCTTCCAGCCTTCCTTC-
CT, Reverse:AGCACTGTGTTGGCGTACAG), B2M(For-
ward:TGCTGTCTCCATGTTTGATGTATCT, Reverse:TC-
TCTGCTCCCCACCTCTAAGT) respectively following the
manufacturer’s protocol (Applied Biosystem).
Serum Stimulation of Akt Activation and Western Blot
Analysis
DU145 cells were serum-starved (0.2%FBS) for 24 hrs, followed
by 24 hr of continuous incubation in serum starved (0.2%FBS)
media (as the control) and media with 25 mM lactic acid. 20%,
10%, and 5% FBS were applied for 30 mins to induce Akt
activation. Proteins were extracted with PARIS kit (Ambion) and
equal amount of protein samples were loaded to SDS-PAGE gels
and blotted with pSer473 Akt antibody (Cell signaling) and other
indicated antibodies.
Glucose and Lactate Measurement
WiDr and SiHa cells were plated in six-well dishes (800,000 cells
per well). The next day fresh media of respective conditions,
including control, 25 mM lactic acidosis, 25 mM sodium lactate,
acidosis of pH 6.7, pH 6.5 and pH 6.0 were applied to cells with
the continuous incubation of 48 hrs under either normoxia or
hypoxia (0.5% O2). After 48hr incubation, media were collected
for glucose (ACCU-CHECK, Roche) and lactate (ARKRAY)
measurements and normalized against cell number to obtain the
glucose consumption/lactate production per million cells.
ATP Determination
SiHa cells were plated at the density of 2610
4 cells/ml. On the
next day, respective media of control and 25 mM lactic acidosis, as
well as media containing drug inhibitors, 2-DG and rotenone
(Sigma), would be applied. They will then be incubated under
normoxia and hypoxia (1% oxygen) respectively. ATP was
measured by ATPlite 1 step luminescence ATP detection assay
system kit with the protocol provided by the manufacturer after 48
and 72 hours (Perkin Elmer). To prevent the interference caused
by different colors of control versus lactic acidosis media, we
replaced culture media with PBS right before the addition of
substrate solution.
Supporting Information
Figure S1 The pathway activities of hypoxia (A) and lactic
acidosis (B) signatures were estimated as probability (Y-axis) by
binary regression models in the HMECs exposed to indicated
treatments (control, lactic acidosis, hypoxia and combined lactic
acidosis and hypoxia, X-axis).
Found at: doi:10.1371/journal.pgen.1000293.s001 (1.02 MB EPS)
Figure S2 The change in gene expression in the indicated
conditions for a set of genes whose expression is induced (A) or
repressed (B) only in the presence of both hypoxia and lactic
acidosis.
Found at: doi:10.1371/journal.pgen.1000293.s002 (3.02 MB EPS)
Figure S3 The confirmation of the induction of ERBB3 and
SOD2 expression by acidosis using real time RT-PCR.
Found at: doi:10.1371/journal.pgen.1000293.s003 (1.09 MB EPS)
Figure S4 The prognostic values of gene signatures reflecting
hypoxia (A, C) and lactic acidosis (B, D) response among the
patients treated (A, B) and untreated (C, D) with tamoxifen in the
Sotiriou datasets. The graphs show Kaplan-Meier curves for two
patient subsets simply split on the median signature level in each
case, for visual presentation. The p-values are for regression
coefficients of the signature in the survival model analysis.
Found at: doi:10.1371/journal.pgen.1000293.s004 (0.93 MB EPS)
Figure S5 Prognostic values of predictive model based on
different combination of gene signatures and clinical variables.
The breast cancers are separated in (A) based on hypoxia, lactic
acidosis response and nodal status; in (B) based on hypoxia, lactic
acidosis response, tumor size, ER status and nodal status; in (C)
tumor size, ER status and nodal status. The graphs show Kaplan-
Meier curves for two patient subsets simply split on the median
signature level in each case, for visual presentation. The p-values
are for regression coefficients of the signature in the survival model
analysis.
Found at: doi:10.1371/journal.pgen.1000293.s005 (1.31 MB EPS)
Figure S6 Genes in the TCA cycle gene set are highly enriched
in the tumors with high lactic acidosis using GSEA.
Found at: doi:10.1371/journal.pgen.1000293.s006 (0.02 MB
PNG)
Figure S7 Breast samples in the Pawitan data set arranged from
left to right by descending hypoxia score (top row). The expression
of genes in TCA cycles in these samples is shown in heat map,
orange color being higher expression while blue color being lower
expression, together with hypoxia score.
Found at: doi:10.1371/journal.pgen.1000293.s007 (0.57 MB EPS)
Figure S8 Higher hypoxia response of TCA cycle genes was
associated with better prognosis, in contrast to the association with
poor prognosis for hypoxia genelists (A). On the other hand, TCA
cycle genes of lactic acidosis response were not associated with
differences in clinical outcome (B).
Found at: doi:10.1371/journal.pgen.1000293.s008 (1.87 MB EPS)
Table S1 Estimated posterior probability and corresponding
Bayesian p-value (1-probability) for gene probe sets showing
responses to hypoxia, lactic acidosis and acidosis.
Found at: doi:10.1371/journal.pgen.1000293.s009 (10.86 MB
XLS)
Table S2 GO terms enrichments (with p values) for genes which
are upregulated and downregulated in HMECs under lactic
acidosis.
Found at: doi:10.1371/journal.pgen.1000293.s010 (0.06 MB
XLS)
Table S3 GO terms enrichments (with p values) for genes which
are upregulated and downregulated in HMECs under hypoxia.
Found at: doi:10.1371/journal.pgen.1000293.s011 (0.03 MB
XLS)
Table S4 The comparison between GO term enrichment under
hypoxia and lactic acidosis.
Found at: doi:10.1371/journal.pgen.1000293.s012 (0.02 MB
XLS)
Table S5 The expression mean-centered values of indicated
MCT family proteins under hypoxia and lactic acidosis.
Found at: doi:10.1371/journal.pgen.1000293.s013 (0.02 MB
XLS)
Table S6 The lists of genes which are strongly induced or
repressed (top 1% probability) under lactic acidosis and hypoxia.
Found at: doi:10.1371/journal.pgen.1000293.s014 (0.18 MB
XLS)
Lactic Acidosis Response in Cancer
PLoS Genetics | www.plosgenetics.org 14 December 2008 | Volume 4 | Issue 12 | e1000293Table S7 Gene sets enriched in the four expression datasets of
breast cancers with high vs. low lactic acidosis pathways from the
GSEA analysis.
Found at: doi:10.1371/journal.pgen.1000293.s015 (0.05 MB
XLS)
Table S8 The GO terms enriched for genes used for the analysis
of glycolysis pathways.
Found at: doi:10.1371/journal.pgen.1000293.s016 (0.02 MB
TXT)
Table S9 p-values for the changes in gene expression under
lactic acidosis and hypoxia for the listed glycolysis genes.
Found at: doi:10.1371/journal.pgen.1000293.s017 (0.02 MB
XLS)
Table S10 Connectivity map analysis of the lactic acidosis gene
signatures.
Found at: doi:10.1371/journal.pgen.1000293.s018 (0.09 MB
XLS)
Table S11 Relationship between lactic acidosis signature and
Akt pathway activities in different tumor expression datasets.
Found at: doi:10.1371/journal.pgen.1000293.s019 (0.04 MB
XLS)
Text S1 Statistical supplement. Details of Bayesian factor
regression models and survival analyses.
Found at: doi:10.1371/journal.pgen.1000293.s020 (0.14 MB PDF)
Acknowledgments
We appreciate the technical assistance from Vivian Lentchitsky, the critical
comments on the manuscripts from Gregory LaMonte and materials/
reagents from Bala Blakumaran.
Author Contributions
Conceived and designed the experiments: JLYC MW JTC. Performed the
experiments: JLYC TS JW JTC. Analyzed the data: JLYC JEL SM JN MD
MW JTC. Contributed reagents/materials/analysis tools: JEL JTC. Wrote
the paper: JLYC JEL JN MW JTC.
References
1. Vaupel P (2004) Tumor microenvironmental physiology and its implications for
radiation oncology. Semin Radiat Oncol 14: 198–206.
2. Helmlinger G, Yuan F, Dellian M, Jain RK (1997) Interstitial pH and pO2
gradients in solid tumors in vivo: high-resolution measurements reveal a lack of
correlation. Nat Med 3: 177–182.
3. Vaupel P, Hockel M (2000) Blood supply, oxygenation status and metabolic
micromilieu of breast cancers: characterization and therapeutic relevance.
Int J Oncol 17: 869–879.
4. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat
Rev Cancer 4: 891–899.
5. Cardone RA, Casavola V, Reshkin SJ (2005) The role of disturbed pH dynamics
and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 5: 786–795.
6. Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and
therapeutics. Trends Mol Med 8: S62–67.
7. Harris AL (2002) Hypoxia–a key regulatory factor in tumour growth. Nat Rev
Cancer 2: 38–47.
8. Huang WC, Swietach P, Vaughan-Jones RD, Ansorge O, Glitsch MD (2008)
Extracellular acidification elicits spatially and temporally distinct Ca2+ signals.
Curr Biol 18: 781–785.
9. Xu L, Fidler IJ (2000) Acidic pH-induced elevation in interleukin 8 expression by
human ovarian carcinoma cells. Cancer Res 60: 4610–4616.
10. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, et al. (2001) Hypoxia and
acidosis independently up-regulate vascular endothelial growth factor transcrip-
tion in brain tumors in vivo. Cancer Res 61: 6020–6024.
11. Shi Q, Le X, Wang B, Abbruzzese JL, Xiong Q, et al. (2001) Regulation of
vascular endothelial growth factor expression by acidosis in human cancer cells.
Oncogene 20: 3751–3756.
12. Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S (2004) HIF activation by pH-
dependent nucleolar sequestration of VHL. Nat Cell Biol 6: 642–647.
13. Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, et al. (2004) A unique
pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 207:
3189–3200.
14. Moellering RE, Black KC, Krishnamurty C, Baggett BK, Stafford P, et al.
(2008) Acid treatment of melanoma cells selects for invasive phenotypes. Clin
Exp Metastasis 25: 411–425.
15. Zieker D, Schafer R, Glatzle J, Nieselt K, Coerper S, et al. (2008) Lactate
modulates gene expression in human mesenchymal stem cells. Langenbecks
Arch Surg 393: 297–301.
16. Nowik M, Lecca MR, Velic A, Rehrauer H, Brandli AW, et al. (2008) Genome-
wide gene expression profiling reveals renal genes regulated during metabolic
acidosis. Physiol Genomics 32: 322–334.
17. Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in
carcinogenesis and tumor progression. Semin Cancer Biol 18: 330–337.
18. Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis.
Nat Rev Cancer 8: 56–61.
19. Laconi E (2007) The evolving concept of tumor microenvironments. Bioessays
29: 738–744.
20. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2005) Oncogenic pathway
signatures in human cancers as a guide to targeted therapies. Nature.
21. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, et al. (2006) Gene
Expression Programs in Response to Hypoxia: Cell Type Specificity and
Prognostic Significance in Human Cancers. PLoS Med 3: e47.
22. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, et al. (2003) A
mechanism of cyclin D1 action encoded in the patterns of gene expression in
human cancer. Cell 114: 323–334.
23. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, et al. (2004) Gene
Expression Signature of Fibroblast Serum Response Predicts Human Cancer
Progression: Similarities between Tumors and Wounds. PLoS Biol 2: E7.
24. Sorensen BS, Hao J, Overgaard J, Vorum H, Honore B, et al. (2005) Influence
of oxygen concentration and pH on expression of hypoxia induced genes.
Radiother Oncol 76: 187–193.
25. Sorensen BS, Alsner J, Overgaard J, Horsman MR (2007) Hypoxia induced
expression of endogenous markers in vitro is highly influenced by pH. Radiother
Oncol 83: 362–366.
26. Lucas J, Carvalho C, Wang Q, Bild A, Nevins J, et al. (2006) Sparse statistical
modelling in gene expression genomics; Do Kea, ed. pp 155–176.
27. Seo DM, Goldschmidt-Clermont PJ, West M (2007) Of mice and men: Sparse
statistical modelling in cardiovascular genomics. Annals of Applied Statistics.
28. Chang JT, Nevins JR (2006) GATHER: a systems approach to interpreting
genomic signatures. Bioinformatics 22: 2926–2933.
29. Adams DJ, Wahl ML, Flowers JL, Sen B, Colvin M, et al. (2006) Camptothecin
analogs with enhanced activity against human breast cancer cells. II. Impact of
the tumor pH gradient. Cancer Chemother Pharmacol 57: 145–154.
30. Wahl ML, Pooler PM, Briand P, Leeper DB, Owen CS (2000) Intracellular pH
regulation in a nonmalignant and a derived malignant human breast cell line.
J Cell Physiol 183: 373–380.
31. Mense SM, Sengupta A, Zhou M, Lan C, Bentsman G, et al. (2006) Gene
expression profiling reveals the profound upregulation of hypoxia-responsive
genes in primary human astrocytes. Physiol Genomics 25: 435–449.
32. Chi J-T, Rodriguez EH, Wang Z, Nuyten DSA, Mukherjee S, et al. (2007) Gene
Expression Programs of Human Smooth Muscle Cells: Tissue-Specific
Differentiation and Prognostic Significance in Breast Cancers. PLoS Genetics
3: e164.
33. Huang E, Ishida S, Pittman J, Dressman H, Bild A, et al. (2003) Gene expression
phenotypic models that predict the activity of oncogenic pathways. Nat Genet
34: 226–230.
34. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression
profiling in breast cancer: understanding the molecular basis of histologic grade
to improve prognosis. J Natl Cancer Inst 98: 262–272.
35. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression
profiling spares early breast cancer patients from adjuvant therapy: derived and
validated in two population-based cohorts. Breast Cancer Res 7: R953–964.
36. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that
mediate breast cancer metastasis to lung. Nature 436: 518–524.
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005)
Gene set enrichment analysis: a knowledge-based approach for interpreting
genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
38. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression
uncovers a link between glycolysis, mitochondrial physiology, and tumor
maintenance. Cancer Cell 9: 425–434.
39. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53
regulates mitochondrial respiration. Science 312: 1650–1653.
40. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a
p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107–120.
41. Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated
expression of pyruvate dehydrogenase kinase: a metabolic switch required for
cellular adaptation to hypoxia. Cell Metab 3: 177–185.
42. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1
mediates adaptation to hypoxia by actively downregulating mitochondrial
oxygen consumption. Cell Metab 3: 187–197.
Lactic Acidosis Response in Cancer
PLoS Genetics | www.plosgenetics.org 15 December 2008 | Volume 4 | Issue 12 | e100029343. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, et al. (2007) HIF-1
inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal
cell carcinoma by repression of C-MYC activity. Cancer Cell 11: 407–420.
44. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The
Connectivity Map: using gene-expression signatures to connect small molecules,
genes, and disease. Science 313: 1929–1935.
45. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway
in human cancer. Nat Rev Cancer 2: 489–501.
46. Franch HA, Raissi S, Wang X, Zheng B, Bailey JL, et al. (2004) Acidosis impairs
insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in
muscle cells: consequences on proteolysis. Am J Physiol Renal Physiol 287:
F700–706.
47. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression
signature for p53 status in human breast cancer predicts mutation status,
transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102:
13550–13555.
48. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, et al. (2004) mTOR
inhibition reverses Akt-dependent prostate intraepithelial neoplasia through
regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10: 594–601.
49. Persad S, Attwell S, Gray V, Mawji N, Deng JT, et al. (2001) Regulation of
protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase:
critical roles for kinase activity and amino acids arginine 211 and serine 343.
J Biol Chem 276: 27462–27469.
50. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, et al. (2004) Akt
stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892–3899.
51. Nevins JR, Potti A (2007) Mining gene expression profiles: expression signatures
as cancer phenotypes. Nat Rev Genet 8: 601–609.
52. Gottlieb E, Tomlinson IP (2005) Mitochondrial tumour suppressors: a genetic
and biochemical update. Nat Rev Cancer 5: 857–866.
53. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK (2002) Acid production
in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin
Cancer Res 8: 1284–1291.
54. Costantini P, Jacotot E, Decaudin D, Kroemer G (2000) Mitochondrion as a
Novel Target of Anticancer Chemotherapy. J Natl Cancer Inst 92: 1042–1053.
55. Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, et al. (2005)
The glucose dependence of Akt-transformed cells can be reversed by
pharmacologic activation of fatty acid beta-oxidation. Oncogene 24: 4165–4173.
56. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, et al. (2001)
Elevated tumor lactate concentrations predict for an increased risk of metastases
in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349–353.
57. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, et al. (2000)
High lactate levels predict likelihood of metastases, tumor recurrence, and
restricted patient survival in human cervical cancers. Cancer Res 60: 916–921.
58. Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor
malignancy. Semin Radiat Oncol 14: 267–274.
59. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, et al. (2001)
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:
1337–1343.
60. Mayer A, Hockel M, Vaupel P (2005) Carbonic anhydrase IX expression and
tumor oxygenation status do not correlate at the microregional level in locally
advanced cancers of the uterine cervix. Clin Cancer Res 11: 7220–7225.
61. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, et al. (2001)
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of
hypoxia: correlations with tumor oxygen measurements and prognosis in locally
advanced carcinoma of the cervix. Cancer Res 61: 6394–6399.
62. Hedley D, Pintilie M, Woo J, Morrison A, Birle D, et al. (2003) Carbonic
anhydrase IX expression, hypoxia, and prognosis in patients with uterine
cervical carcinomas. Clin Cancer Res 9: 5666–5674.
63. Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller-Klieser W (1995)
Correlation of high lactate levels in human cervical cancer with incidence of
metastasis. Cancer Res 55: 4757–4759.
64. Gerweck LE (1998) Tumor pH: implications for treatment and novel drug
design. Semin Radiat Oncol 8: 176–182.
65. Shin HJ, Kim JY, Yoo CW, Roberts SA, Lee S, et al. (2007) Carbonic anhydrase
9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine. J Cancer
Res Clin Oncol.
66. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:
14863–14868.
67. Carvalho C, Chang J, Lucas J, Wang Q, Nevins JR, et al. (2007) High-
dimensional sparse factor modeling: Applications in gene expression genomics.
Journal of American Statistical Society.
Lactic Acidosis Response in Cancer
PLoS Genetics | www.plosgenetics.org 16 December 2008 | Volume 4 | Issue 12 | e1000293